Director
Jeremy Sturgess-Smith
Jeremy joined the Hartford board in 2025 and leads the day to day management of the company and its portfolio.
He co-founded Ananda Pharma and led its IPO in July 2018. As finance director he has led every capital raise since, including more than £2.2m in 2024, and led the acquisitions of MRX Global and DJT Plants. He owns the group's audit, budgeting, tax and investor relations functions and sits on the boards of MRX Global and MRX Medical.
At Gem Resources, where he is chief operating officer, he drove the company's re-admission to the London Stock Exchange in 2022 and worked on the acquisition of critical mineral licences in Zambia, the Gravelotte emerald mine in South Africa and the Curlew emerald project in Australia. He was part of the team that restructured and refinanced Cloudbreak Discovery. He is also a director of Laser Green, an industrial laser cleaning business held by Hartford, and a co-founder of Mendia, a women's health technology company.
jss@hartfordcorporate.com
Director
Melissa Sturgess
Melissa has been a director of Hartford since 2017. She holds a BSc and an MBA from the University of Western Australia and has served as a director and chairman of companies quoted in London and Australia since 2001.
She was a founding director of Sylvania Resources, a platinum group metals producer in South Africa, and of Ferrum Crescent and Churchill Mining. She chaired Nyota Minerals in Ethiopia and Luiri Gold in Zambia, where she negotiated the reinstatement of the company's mining licence with the government, and is a non-executive director of Lexington Gold, chairing its audit and remuneration committees. She has worked across southern and eastern Africa, the Philippines, Indonesia, Georgia and Israel.
Since 2018 she has been chief executive of Ananda Pharma, a clinical stage biotech whose CBD formulation is in two Phase II randomised controlled trials at the University of Edinburgh. She was named Executive of the Year at the 2019 Malta Cannabiz Awards, and in 2024 the most influential chief executive in cannabinoid medicines in the United Kingdom by CEO Monthly.
ms@hartfordcorporate.com